HIV & AIDS

/ /

Hornet Joins Undetectable = Untransmittable Campaign to Fight HIV Stigma

  Today, Hornet, the world’s premier gay social network, announced the company will join the international Undetectable = Untransmittable (U=U) campaign becoming the first gay social network to support the initiative. Hornet, which has a longstanding history of community engagement around gay men’s health, is working to combat HIV stigma by continuing to raise awareness that an undetectable viral load means HIV is untransmittable. This partnership will utilize one of the largest global LGBTQ platforms to empower people living with HIV, stimulate conversations about sexual health and advance the principle that access to health care is a fundamental human right. […]

/ /

HIV Drugs Control Disease – for Those Who Can Afford Them

This article originally appeared on Massive. In the past few decades, HIV has gone from being a fatal diagnosis to a manageable disease. Although no known cure exists, researchers have developed antiretroviral therapies (ARTs) that stop the HIV virus’ ability to make copies of itself in the body. Effectively, this means that individuals with HIV who consistently comply with the regimen can keep their infection under control and live a long life. ART takes a multi-pronged approach to combating HIV – patients often have to take at least three different drugs daily to suppress their infection. With that regime comes […]

/ /

PrEP and Reaching People of Color, Trans Women, and Young People

,

PrEP is an effective method of preventing HIV that is available and can be affordable to most people who want to use it. But not everyone at risk for HIV knows about it, and many people who could benefit from PrEP believe it’s not for them. A recent panel discussion hosted by New America Media and the San Francisco Department of Public Health explored this very issue with six representatives working in the field of HIV prevention in San Francisco. Speaking about their work and the diverse communities they serve, the panelists shared some of the important barriers that people […]

/

Why Relying on Someone Else’s PrEP Isn’t a Good Idea

It’s becoming even easier for gay and bi men to search for and find partners on PrEP. Many people talk to partners ahead of time about their PrEP use. Social networking apps, like Grindr, also allow users to find partners who use PrEP (or who use other HIV prevention strategies like treatment as prevention). “A lot of people will list their HIV status in their profile, or their PrEP use in their profile. So it’s pretty easy—and I think pretty common—to serosort or PrEP-sort on apps,” said Kay Nilsson, health advocacy coordinator at San Francisco AIDS Foundation. One word of […]

/ /

UNAIDS Calls to Quicken the Pace of Action to End AIDS

The President of Uganda, Yoweri Museveni, in collaboration with UNAIDS, brought together six heads of state or government to accelerate action and get countries on the Fast-Track to end AIDS. World leaders joined around 500 partners from government, the private sector and civil society on the sidelines of the United Nations General Assembly to reinvigorate political leadership around HIV. The Fast-Track approach is saving more and more lives. In 2016, 19.5 million people—more than half the 36.7 million people living with HIV—were accessing life-saving treatment. The number of people who died from AIDS-related illnesses has been reduced by nearly half […]

/

IAS 2017: Progress on PrEP, treatment as prevention, and HIV cure science

While the world’s top HIV experts reported no earth shattering progress in preventing, treating or curing HIV at the 9th IAS Conference on HIV Science (IAS 2017), which took place in July in Paris, it did serve as an important marker of progress. HIV researchers revealed new data that further strengthened the case for PrEP and HIV treatment as prevention — and issued a resounding declaration that a person with full viral suppression is essentially incapable of passing on HIV to their sex partners. On the other hand, a joint meeting of HIV and cancer scientists, just before IAS 2017, […]

/ /

NMAC Launches Campaign to Fight Proposed Cuts to HIV Services

Today, NMAC Launches “Save Our Services,” an innovative campaign created to empower Americans across the country in fighting the proposed federal budget cuts that would cause severe harm to vital HIV treatment and prevention services. SOS will enlist the advocacy of community volunteers to contact their representatives in Congress both in their home offices during the August recess and on Capitol Hill for the official  “HIV/STD Action Day” on Sept. 6. This Day of Action will precede the opening of NMAC’s annual U.S. Conference on AIDS, which will run from Sept. 7 – 10. More information about “Save Our Services” […]

/

FDA Application Accepted for HIV Drug with New Mechanism of Action

Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced Friday that it has been notified by its partner, TaiMed Biologics, Inc., that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ibalizumab as a treatment for multidrug resistant Human Immunodeficiency Virus-1 (MDR HIV-1). If approved, ibalizumab will be the first antiretroviral treatment (ART) with a new mechanism of action to be introduced in nearly 10 years and the only treatment that does not require daily dosing. “We are excited to be one step closer to potentially bringing an important new treatment, with a new mechanism […]

/ /

AIDS United Releases Statement for Providing Trans-affirming HIV Medical Care, Support Services and Funding

In a community-created consensus statement released today, AIDS United provides critical guidance for clinical providers, funders and social service providers to strengthen their understanding of how best to engage and support transgender communities. The statement provides concrete and measurable steps organizations can take to improve their approach to HIV work in transgender communities and was drafted by 12 transgender leaders at a think tank convened by AIDS United and generously supported by Janssen Therapeutics, Division of Janssen Products, LP. The transgender community is critically affected by HIV and faces unique challenges accessing HIV care. A landmark 2013 study estimates that […]

/ /

PleasePrEPMe.org seeks to expand access to PrEP within California

  HIVE (hiveonline.org) and Project Inform (projectinform.org) are pleased to announce the hiring of three key positions for supporting PrEP services within California and nationally through expanded navigation services at PleasePrEPMe.org (PPM). The launch date of these free new services is being planned for early April. “HIVE launched PleasePrEPMe.org in 2015 to provide consumers a search engine to find PrEP-friendly clinicians within California,” stated Shannon Weber, Director at HIVE. “This year, with a grant from the state department of health, we’re excited to be expanding the original site to include an online chat function as well as provide navigation assistance […]

«‹ 24 25 26 27›»